相关实验视频

Updated: Jun 4, 2025

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

针对髓状细胞的免疫检查点:目前的状况和未来的方向

Chuhan Ma¹, Yang Li¹, Min Li²

¹Department of General Surgery, Shengjing Hospital of China Medical University, ShenyangLiaoning Province, 110004, China.

Cancer immunology, immunotherapy : CII

|January 3, 2025

概括

准髓质免疫检查点可以逆转瘤免疫抑制. 结合纳米技术等疗法提供了更安全,更有效的癌症治疗策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
癌症研究癌症研究

背景情况:

骨髓状细胞在瘤中丰富,有助于瘤微环境 (TME) 内的免疫抑制.
髓状细胞表达免疫检查点分子,类似于T细胞,促进免疫抑制的表型.
在TME中,关键的髓状细胞种群包括巨细胞,中性粒细胞,树突细胞和髓状细胞衍生的抑制细胞.

研究的目的:

审查主要髓状细胞类型的促进瘤功能和免疫检查点表达.
探索作为癌症治疗策略,准髓质免疫检查点的潜力.
讨论精确的骨髓质检查点准的先进治疗方法.

主要方法:

文献综述总结了关于髓状细胞功能和免疫检查点的当前研究.
分析特定髓状细胞子集在瘤免疫抑制中的作用.
评估新兴的治疗策略,包括纳米技术,细胞疗法和双特异抗体.

主要成果:

髓状细胞通过各种机制对免疫抑制性TME有显著的贡献.
免疫检查点在髓状细胞上表达,提供潜在的治疗点.
准髓质检查点可能会逆转免疫抑制并增强抗瘤免疫力.

结论:

阻断髓状细胞上的免疫检查点是一个有希望的策略,以克服TME介导的免疫抑制.
使用纳米技术,细胞疗法和双特异性抗体的组合疗法可以实现精确准髓质检查点.
这些有针对性的方法旨在提高癌症治疗的疗效,同时尽量减少系统性不良影响,平衡治疗结果和患者安全.

关键词:

免疫检查站检查站骨髓状细胞是骨髓状细胞.纳米疗法是一种纳米疗法.瘤微环境是一个微环境.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

相关概念视频

Cell-surface Signaling

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.